Updated warning for Aranesp and similar drugs
Hi all,
Unfortunately Aranesp and similar drugs seem to give more complications and EMEA (corresponding to FDA in Europe) is updating the warning: http://www.emea.europa.eu/pdfs/human...33396308en.pdf Kind regards Birgitta-A |
Thanks for posting this.
Marlene |
Warning for Aranesp
Hi Marlene,
The question of giving erythropoiesis-stimulating agents like Aranesp is very complicated :confused:. From one of the other four support groups I belong to we got this abstract today: http://theoncologist.alphamedpress.o.../13/6/715?etoc The insurance companies will probably be still more restrictive with permission to give Aranesp in the future. Kind regards Birgitta-A |
I think this is the same info the US looked at several months ago. There was debate about whether or not it affected MDS patients. It was decided it did not present a problem for MDS (and I think other non-tumor cancers).
Zoe |
Aranesp
Hi Zoe,
I hope you are right but this sentense makes me wonder: "Epoetin-containing medicines are indicated in patients with chronic renal failure and for the treatment of anaemia in symptomatic patients with non-myeloid tumours receiving chemotherapy." Kind regards Birgitta-A |
Birgitta,
The US warnings said the same thing. Using it for MDS is an off-lable use, although after all this time I don't know why it still is. Zoe |
All times are GMT -4. The time now is 08:10 AM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org